VMP 39706911000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-beneldopa 12.5mg/50mg dispersible tablets sugar free
BNF code 0409010K0AAAMAM
Virtual Therapeutic Moiety Co-beneldopa
Date identifier became valid 26 May 2021
Previous product identifier 323110001
Basis of preferred name BAN - British Approved Name
Date of name applicability 1 Sep 2007
Previous name Co-beneldopa 12.5mg/50mg dispersible tablets
Basis of previous name BAN - British Approved Name
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Benserazide hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 391821005
Strength value numerator 12.500
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Levodopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Dispersible tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Madopar 50mg/12.5mg dispersible tablets (Roche Products Ltd)
Virtual Medicinal Product Packs
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free 100 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback